Recovery, symptoms, and well-being one to five years after lung transplantation -A multi-centre study Background: In recent years, survival after lung transplantation has remained largely unchanged despite improvements in short-and intermediate-term survival, indicating the need to identify factors associated with recovery and long-term survival. Very little is known about how lung recipients recover after lung transplantation and whether such factors are related to symptom distress and wellbeing. This constitutes the rationale of the study. Aim: The aim was to explore symptom prevalence and distress as well as the degree of self-reported perceived recovery and well-being 1-5 years after adult lung transplantation. Method: This multicentre, cross-sectional nationwide study includes 117 lung recipients due for follow-up at 1 year (n = 35), 2 years (n = 28), 3 years (n = 23), 4 years (n = 20) and 5 years (n = 11). Three different self-assessment instruments were utilised; The Postoperative Recovery Profile, the Organ Transplant Symptom and Well-Being Instrument, and the Psychological General Well-Being Instrument. Ethical approval of the study was obtained.
Introduction
During the past three decades, lung transplantation (LuTx) has become an established and effective treatment for patients with end-stage pulmonary disease, (1, 2) and more than 50 000 single and double lung transplantations (LuTxs) have been performed worldwide (3) . Very little is known about how lung recipients (LuTRs) perceive their recovery after transplantation. This study aims to address a knowledge gap regarding the extent to which lung transplant recipients recover after transplantation and whether factors such as symptom distress are related to the state of posttransplant recovery. To the best of our knowledge, this multicentre, cross-sectional nationwide study is the first of its kind to explore LuTRs' self-reported, perceived degree of recovery in relation to perceived symptoms and well-being.
What is already known is the fact that posttransplant follow-up is extensive in order to optimise medical therapy. It involves bronchoscopies, biopsies, lab tests, chest radiographs and clinical examinations (2) but also active patient engagement in a variety of health behaviors (4), i.e., self-management. This include intake of medication, regular physical activity, reducing the use of alcohol, smoking cessation, sun-protection, keeping medical appointments (4) as well as self-monitoring of lung function, vital signs and symptoms (5, 6) . Based on a clinical perspective, healthcare professionals expect LuTRs to play an active role in their recovery process. This includes symptom-management, which is part of the concept of self-management. As part of posttransplant care, LuTRs must adhere to a complex self-management regime (7) due to their high rates of infection and acute or chronic rejection (3, 8) .
Previous qualitative studies suggest that the goal after LuTx is not necessarily full recovery without the presence of symptoms, but instead to achieve the experience of health by learning how to adjust to and manage one's symptoms (9, 10) . Therefore, one hypothesis is that it is possible to experience well-being and health despite not being fully recovered in terms of being symptom free.
Symptom experience is a critical posttransplant outcome, possibly affecting self-management. During the recovery process, LuTRs suffer from many different symptoms (11) (12) (13) (14) . Posttransplant symptoms may vary in frequency, time of onset and duration as well as perceived distress but also due to immunosuppressive treatment (11) . There is an association between side-effects from immunosuppressive medications, symptom experience and nonadherence as patients try to decrease their symptom burden by reducing dosage or taking drug-holidays (11) .
Previous research also reveals that depressive and anxiety-related disorders are common after LuTx (15, 16) . In a study including 178 LuTRs, 30% suffered from major depression that developed gradually during the first 2 years posttransplant (17) . Depression at an early stage posttransplant increases the risk of long-term transplantrelated mortality (18) (19) (20) and morbidity (15) with an elevated risk of Bronchiolitis Obliterativt Syndrom (BOS), patient death and graft loss (15) . No evidence-based practice guidelines are available to support LuTRs during recovery. What remains unknown is whether or not a relationship exists between well-being, symptoms and recovery, especially after LuTx, and there is a lack of knowledge regarding the recovery process from a patient perspective as well as the possible impact of symptoms, well-being and health. Despite improvements in shortand intermediate-term survival, long-term survival after LuTx has remained largely unchanged (3) . This indicates an urgent need to identify and improve factors associated with long-term survival. Thus, the aim was to explore symptom prevalence and distress, as well as the degree of self-reported recovery and well-being 1-5 years after adult lung transplantation.
Methods

Study population and ethical approval
This cross-sectional study is part of the Swedish national multicentre study; Self-Management After Thoracic Transplantation (SMATT). Adult LuTRs due for their annual follow-up 1-5 years after transplantation were consecutively included from the two thoracic transplant centres in Sweden. Inclusion criteria were transplant recipients receiving only lungs, Swedish speaking, mentally lucid and not hospitalised at the time of the data collection. The reasons for exclusion were inability to speak Swedish, declining participation or transplanted with both lungs and a heart.
During the data collection period from February 2014 to October 2015, 204 LuTRs were eligible for an annual follow-up and 128 (63%) were included. Practical inclusion difficulties at the outpatient transplant clinics affected the final sample size. Due to inclusion errors nine recipients were included twice in different followup years, which were subsequently corrected. Another two recipients were identified as both heart and lung recipients after the inclusion was made and were thereby removed from the final sample. Thus, the final sample consisted of 117 LuTRs who were due for follow-up at 1 year (n = 35), 2 years (n = 28), 3 years (n = 23), 4 years (n = 20), and 5 years (n = 11).
The Regional Ethical Review Board of southern Sweden granted permission to carry out this study (D-nr. 2014-124). The information provided was kept confidential and stored in accordance with the Swedish personal data act; (21) . Data were gathered from the patients' records after permission was granted in accordance with regulations.
Data collection and instruments
The lung recipients were approached by the nurse at either of the two outpatient transplant clinics with verbal and written information about the study. After consent was obtained the three different self-report instruments (Table 1) were utilised in paper form and handed out by nurses. The participants could either answer the questionnaires while waiting for the examinations and lab results or bring the instruments home and return them in a pre-paid and pre-coded envelope. The Postoperative Recovery Profile (PRP) was used to measure the degree of perceived recovery, graded from fully recovered, almost fully recovered, partly recovered, slightly recovered or not recovered at all (22) . The Organ Transplant Symptom and Well-Being Instrument (OTSWI) was used to measure symptom prevalence, symptom distress, and transplant specific well-being (13) . The Swedish version of the Psychological General Well-Being (PGWB) instrument was employed to measure psychological wellbeing and distress (23) .
Statistical analysis
The SPSS Statistics 24 (SPSS Inc., IBM Corporation, Armonk, N.Y., USA) was used for analysing the data, which were mostly ordinal. Ordered category data are presented with medians and percentiles (P 25 , P 75 ). We used the following statistical analysis to test hypothesis regarding differences between two un-paired groups and relationships between different aspects of well-being and recovery: Chi Square, T-test, Mann Whitney U and Spearman's rho. Also Hierarchical multiple regression was used to answer the question, if we control for the possible effect of age and sex, are the PGWB-sum score and the OTSWI-sum score still capable of predicting a significant amount of variance in recovery? Values of p < 0.05 (two-tailed) were considered statistically significant. The analysis was performed in a step-wise manner.
Perceived recovery was dichotomised into two groups, i.e., reasonably recovered patients represented by the levels fully recovered, almost fully recovered and partly recovered in the PRP-instrument and those not recovered represented by the levels slightly recovered and not recovered at all. Age was dichotomised into two groups, younger or older than 50 years. Length of stay in the ICU was dichotomised into longer or shorter than 7 days. Lung function was defined by Forced Expiratory Volume in 1 second (FEV 1) and the grade of chronic rejection i.e., Bronchiolitis obliterans syndrome (BOS). The BOS grade ranged from 0-3 and was dichotomised into two groups, with or without BOS. Hierarchical multiple regression was used to assess the ability of the PGWB-sum and OTSWI-sum to predict levels of recovery after controlling for the influence of age and sex.
Result
Patient characteristics
Demographics, indication for transplantation and immunosuppressive medications are presented in Table 2 . The mean age of the participants was 54 years (SD 12. 
Recovery
The PRP instrument response rate was 74% (n = 87), where 5.7% (n = 5) were fully recovered and 17.2% (n = 15) were almost fully recovered 1-5 years after LuTx. The recipients who were partly recovered and slightly recovered constituted 46% (n = 40) and 3.4% (n = 3) respectively. In total 27.6% (n = 24) were not recovered at all. Figure 1 presents the degree of recovery on a yearly basis 1-5 years posttransplant. The proportions of recovered LuTRs did not differ between men and women nor between patients younger or older than 50 years.
Characteristics of patients who were not recovered
The response rate on the OTSWI-instrument varied between 93% and 97% (n = 109-113). The LuTRs who were not recovered reported lower transplant specific well-being compared to those who were reasonably recovered in all eight dimensions of the OTSWI instrument Table 1 Self-assessment instruments employed PRP: The 19 questions in the instrument cover different physical and mental symptoms, but also possible limitations in daily occupation and social life. The responses are given on a four point scale, i.e., none, mild, moderate, and severe. The timeframe is specified as how the recipients felt when completing the instrument. The level of recovery is based on the number of 'none' responses, where 19 (out of 19) 'none' responses equal fully recovered continuing with a descending gradient down to <7 'none' responses which equates with not recovered at all. The content validity of the instrument was high and a vast majority of the items showed a high level of intra-patient reliability (30) OTSWI: The 20 questions in the instrument consist of eight factors measuring transplant well-being, fatigue, joint and muscle pain, cognitive functioning, basic activities of daily life (BADL), sleep problems, mood, foot pain, and economy. All eight factors had satisfactory internal convergent validity as well as good item-scale discriminatory validity. Together the eight factors accounted for 86% of the variance. Each response relates to the discomfort of a situation or problem, assessed on a five-point scale ranging from 'not at all'(0), 'a little'(1), 'somewhat'(2) and 'quite a bit'(3) to 'very much' (4). The timeframe was specified as the previous 7 days. The scale has a summary score of 0-80 where lower scores indicate higher well-being. In addition, symptom distress was measured by the degree of discomfort from twenty transplant specific symptoms graded from 'not at all'(0), 'a little'(1), 'somewhat'(2) and 'quite a bit'(3) to 'very much' (4) (13) PGWB: The instrument contains 22 questions constituting six dimensions, anxiety, depressed mood, positive well-being, selfcontrol, general health, and vitality. The timeframe was specified as the previous 7 days. The maximum PGWB-index is 132 (best subjective well-being) where higher scores indicate better health status and psychological well-being with a minimum score of 22 (poorest subjective well-being). A normal sum-score is in the range of 100-105, where women generally tend to report lower well-being than men (31) . The instrument has good internal consistency as well as test-retest reliability and validity (p ≤ 0.001). The p-value for sleep problems was 0.012. The OTSWI sum-score differed between the two recovery groups (p < 0.001). The recipients who were not recovered suffered from more distress in all symptoms except increased appetite, dyspepsia and headache (p < 0.001-0.034). Recipients who were not recovered were a longer time on the ventilator (p = 0.005) and also had a longer intensive care stay (p = 0.001) and total hospital stay (p = 0.005). Among the 27 recipients who were not recovered, 14.8% (n = 4) worked full or part-time.
One year after LuTx, there was a moderate correlation between recovery and time on the ventilator, (r s 0.472), as well as between recovery and length of intensive care stay (r s 0.390). This relationship between recovery and length of time in the intensive care unit was also apparent after 2 and 3 years (r s 0.492 and 0.540).
There were 67% (n = 77) without BOS and 33% with BOS grade 1-3 (n = 38) and two patients where the BOS-grade was missing. Among those with BOS, 12 
018).
Recovery in relation to symptoms and transplant specific wellbeing (OTSWI) There was no relationship between lung function (FEV 1 ) and OTSWI-sum (r s À0.109). The lowest transplant specific well-being, with a possible score ranging from 0 to 80, was reported 4 years after transplantation, median 22 (p 25 = 11; p 75 = 32). There were no differences between male and female recipients in overall transplant specific well-being. In the second and fourth year medians of 4 and 5.5 respectively were reported (min 0, max 12) in the sleep problem dimension. The highest median of fatigue was reported on the fourth year 4.0 (min 0, max 12). Female lung recipients reported worse joint and muscle pain (JMP) (p = 0.012) and sleep problems (SP) (p = 0.04) than their male counterparts.
As shown in Tables 3 and 4 , the five most prevalent symptoms 1-5 years after LuTx were not always experienced as the most distressing ones. Female LuTRs reported worse headache (p = 0.05), nausea (p = 0.02), and dizziness (p = 0.026) than male LuTRs who reported more problems with trembling hands (p < 0.001). The only relationship identified between BOS grade and the 20 investigated symptoms were with dyspnoea (r s = 0.221) and dyspnoea while resting (r s 0.216).
There was a strong correlation between transplant specific well-being (OTSWI-sum score) and recovery 1-5 years after LuTx (r s = 0.741). This correlation was evident each year (r s = 0.655-0.821) with the strongest correlation after 1 year.
Recovery in relation to psychological well-being (PGWB)
The response rate on the PGWB-instrument was 97% (n = 113). A normal PGWB-sum score is in the range of Many recipients had a triple combination of immunosuppressive drugs, which is why frequency is larger than total n included in the study.
100-105. PGWB-sum scores were within or above the range of normal values, indicating good psychological well-being and health status for all years except the fourth, where the median was 93.5 (p 25 = 79.5; p 75 = 109). At the 4-year follow-up 70% (n = 14) reported poor psychological well-being, whereas a majority had reported good psychological well-being at all other annual follow-ups, ranging from 57.1% to 72.7%. When dichotomising the PGWB-sum-score into good psychological well-being (>100) and poor psychological well-being (<100), 55.6% (n = 65) reported good psychological well-being and 41% (n = 48) poor Figure 1 The frequency (N) of lung recipients at each level of recovery at each yearly follow-up. psychological well-being 1-5 years after LuTx, while 3.5% (n = 4) were missing. There was no relationship between lung function (FEV 1 ) and recovery (r s = 0.117). The median of the general health sub-dimension was good in all years, range 14-16 (max 18) . Patients treated on the ventilator for more than 30 hours reported lower general health (p = 0.036). There was no difference regarding age, sex or length of intensive care stay in the dimensions of general health and overall psychological well-being.
There was a strong relationship between recovery and psychological well-being after 1-5 years (r s À0.720). This correlation ranged between r s À0.662 to 0.806 for each individual year with the strongest correlation after 4 years (r s À0.806). There was also a relationship between the sub-dimension of general health and recovery for each year in the range of r s À0.583 to 0.886, with the strongest correlation after 5 years (r s À0.886).
LuTRs who were slightly recovered or not recovered at all reported decreased psychological well-being, median 96 and 79, respectively (p < 0.001). Recipients who were partly, almost or fully recovered reported good psychological well-being and general health (Table 5) .
Together, the OTSWI-sum score and PGWB-sum score explained 54.4% of the variance in recovery after controlling for age and sex (R square change = 0.544, F change (2.81) = 49.79, p < 0.001), with the OTSWI-sum score recording a higher beta value (beta = 0.45, p < 0.001) than the PGWB-sum score (beta = À0.34, p = 0.006).
Discussion
The key findings in this study were:
• Few LuTRs perceive that they are recovered 1-5 years after LuTx.
• There is a strong relationship between perceived recovery and both psychological general well-being and transplant specific well-being.
• No or weak relationship was identified between lung function and perceived recovery as well as both psychological general well-being and transplant specific well-being.
• Transplant specific well-being makes the largest unique contribution to perceived recovery.
• It is possible to be partly recovered and experience good health. To the best of our knowledge, this is the first study to explore the degree of recovery and well-being after LuTx, and the findings imply that changes are required in follow-up care. First, very few (5.7%) LuTRs perceived themselves to be fully recovered and 28% were not recovered at all 1-5 years after transplantation. This raises questions as to whether it is reasonable to expect full recovery in terms of being symptom free, how recovery after transplantation should be defined, and what kind of self-management support is required by the recipients. A previous qualitative study provides transplant nurse practitioners with a framework for the recovery process, as well as the following definition of posttransplant recovery from a patient-perspective;
Posttransplant recovery is a dynamic, demanding process involving a transition from pre-transplant severe illness to a state of experienced health, achieved by adjusting to regained physical, psychological, social and habitual functions. Essential parts of the transitional recovery process consist of symptom management, achieving an optimum level of psychological well-being, social adaptation and reconstructing daily occupations. (10) The framework and definition together with the result of this present study might serve as a guide for the type of self-management support required after LuTx.
One of the most important goals of transplantation is to improve and promote health related quality of life (24) . Our findings demonstrate that the recipients often had a very complicated recovery process characterised by the prevalence of many symptoms and setbacks, where the support of healthcare professionals in the promotion of well-being and health is a key element.
Although LuTx is a life-saving treatment, the goal is not to completely cure a disease or repair a surgical In the subscale General Health (GH) max score is 18 with higher score indicating better health. In the Organ Transplant Symptom and Well-being Instrument (OTSWI), maximum score is 80 and the higher the score, the lower the well-being.
problem but rather to move from an end-stage disease to better health and well-being, albeit characterised by a chronic condition requiring life-long medication that causes side-effects and complications. Health systems and health care today are organised around an acute and reactive model of care that does not meet the needs of patients with chronic conditions and multiple pathologies (25) such as LuTRs. This important fact is often disregarded (25) and therefore follow-up care after LuTx should be reorganised to a multi-professional team approach based on patients' own experience of the recovery process and their chronic condition. The fact that recipients who were not recovered were characterised by lower psychological and transplant specific well-being, as well as higher symptom burden must be acknowledged during the posttransplant follow-up. As depression has proven to be a predictor of an increased risk of mortality (19, 20) and morbidity (15) , it is of the utmost importance to identify those recipients who are slightly or not recovered at all, after which the follow-up care should be specifically designed to find recipients with lower well-being and screen them for depression. In two review studies it is recommended that healthcare professionals should assess transplant recipients' psychological well-being and screen for depression as part of routine clinical care (16, 20) .
A majority of the recipients were partly recovered and despite the presence of numerous symptoms still reported well-being and good general health. In a previous qualitative study the LuTRs described several symptoms and complications, yet experienced health (9) . Furthermore, the most frequent symptoms were not always the most distressing ones, thus both symptom frequency and burden must be measured posttransplant. One symptom that is thoroughly investigated is chronic pain after LuTx, which might further affect recovery and requires pain assessment during follow-up (26, 27) .
To our surprise there is only a weak relationship with the present lung function, presence of chronic rejection and recovery. Also no relationship was identified between lung function and well-being. Thus it suggests that objective measures of recovery by means of lung function might not be enough as a recovery marker. The question as to why LuTRs can experience health despite the presence of symptoms might be explained by the fact that an adaptation process occurs. Adaptive responses contribute to health, whereas ineffective or maladaptive responses do not (28) . When tailoring follow-up care for LuTRs, adaptation as a means for achieving health should be considered and supported by the transplant team. One of the most important goals of transplant nursing is health-promotion (24) , which consists of both support provided by healthcare professionals at the clinics and hospitals and self-management support, which is a major part of self-care when at home. Self-management support is a key component of effective chronic illness management and improves patient outcomes (29) . Understanding the recovery process is a prerequisite for the development of guidelines to enable healthcare professionals to conduct health promotion and enhance wellbeing. Transplant nurses involved in the follow-up care should emphasize symptom-management support in order to minimise symptom burden, but a focus on health management is equally important. In the light of our study where a majority of the recipients experienced well-being and good health, the key mission for transplant nurses should be health promotion, preferably at an outpatient clinic led by advanced nurse practitioners.
Future prospective studies are important in order to investigate the recovery process trajectory and identify predictors of both a complicated and a positive course of recovery. Furthermore, greater focus should be placed on the recipient's adaptive strategies for attaining well-being and health.
Methodological considerations
The cross-sectional design of our study prevents us from identifying any causal relationships. A selection bias may be apparent due to our exclusion of non-Swedish speaking, hospitalised recipients and the loss of patients due to transplant mortality, which resulted in a fairly small sample in the fifth year. In addition to the above-mentioned selection bias, the context of medical care context should be taken into consideration as it might not only differ internationally but also nationally at the two transplant centres in Sweden.
Conclusion
In conclusion, there is a high frequency of symptoms after LuTX. Despite the fact that few recipients achieve full recovery after LuTx, well-being can still be experienced. Objective signs such as lung function is not enough as recovery markers since they are not related to the lung recipients' illness experience. The low degree of perceived recovery is related to poor psychological wellbeing while high symptom distress might be a marker of an increased need for self-management support.
Clinical implications
• The degree of self-perceived recovery and symptom distress should be systematically evaluated after LuTx in order to identify recipients with impaired wellbeing.
• The goal of posttransplant follow-up after LuTx should be health promotion by supporting recipients' symptom-and health management as well as adaptive strategies.
• Long-term follow-up should include health promotion at an outpatient clinic, preferably managed by a multi-professional team led by advanced nurse practitioners.
